GHRS
GH Research PLC
NASDAQ · Healthcare · Biotechnology · IE
$28.23
+1.11%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-17.3%
Return on equity
-16.7%
Return on assets
-19.9%
Return on invested capital
0.00x
Asset turnover
-$52.4M
Cash from operations
$5.28
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026